undamentalytics Newsletter
Sign in

Chemed Corp income statement

In fiscal 2025, Chemed Corp reported revenue of $2.53bn, up 4.1% on the year before, operating income of $338m (a 13.4% margin) and net income of $265m, or $18.34 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue1,1901,2811,3561,4301,4131,4561,5431,5771,6671,7831,9392,0802,1392,1352,2642,4312,5302,661
Cost of revenue8359069701,0331,0091,0351,0881,1151,1511,2281,3211,3781,3691,3701,4661,5771,7071,769
Gross profit356375385397405422456461516555617701770765799854823893
Selling, general and administrative197202202209216223238244277271306330367359395424417446
Operating income126144154156133168184179113244257390343343341366338371
Interest expense12121415158444552253225
Income before tax121134141146124163180177117240262396350330350399356382
Income tax4752555747637068193442778280789791100
Net income74828689779911010998206220319269250273302265282
Diluted EPS$3.24$3.55$4.10$4.62$4.16$5.57$6.33$6.48$5.86$12.23$13.31$19.48$16.85$16.53$17.93$19.89$18.34$20.92
Diluted shares (average)23m23m21m19m19m18m17m17m17m17m17m16m16m15m15m15m14m13m
EBITDA148168179182163199218213149282303446402403401430403433

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: AVAH vs CHECHE vs HIMSCHE vs PRVA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Chemed Corp's SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Chemed Corp.